theory clinical_105_5
imports Main

begin

typedecl entity
typedecl event

consts
  Trastuzumab :: "entity ⇒ bool"
  HER2 :: "entity ⇒ bool"
  ExtracellularDomain :: "entity ⇒ bool"
  Bind :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Specifically :: "event ⇒ bool"
  Mutation :: "entity ⇒ bool"
  IntracellularDomain :: "entity ⇒ bool"
  Affect :: "event ⇒ bool"
  HER2V777L :: "entity ⇒ bool"
  TyrosineKinaseDomain :: "entity ⇒ bool"
  Located :: "event ⇒ bool"
  Target :: "event ⇒ bool"
  Resistance :: "entity ⇒ bool"
  AntibodyTherapy :: "entity ⇒ bool"
  Lead :: "event ⇒ bool"
  Cause :: "event ⇒ bool"
  To :: "entity ⇒ entity ⇒ bool"

(* Explanation 1: Trastuzumab binds specifically to the HER2 extracellular domain, and this binding does not affect mutations located in the intracellular kinase domain. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. Trastuzumab x ∧ HER2 y ∧ ExtracellularDomain y ∧ Bind e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Specifically e1 ∧ Mutation z ∧ IntracellularDomain z ∧ Affect e2 ∧ Agent e2 x ∧ Patient e2 z ∧ ¬Affect e2"

(* Explanation 2: The HER2 V777L mutation is located in the intracellular tyrosine kinase domain, which is not targeted by trastuzumab, and this location can lead to resistance to antibody therapy. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. HER2V777L x ∧ Mutation x ∧ IntracellularDomain y ∧ TyrosineKinaseDomain y ∧ Located e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Trastuzumab z ∧ Target e2 ∧ Agent e2 z ∧ Patient e2 y ∧ ¬Target e2 ∧ Resistance y ∧ AntibodyTherapy y ∧ Lead e2 ∧ Agent e2 y ∧ Patient e2 x"

(* Explanation 3: The HER2 V777L mutation may cause resistance to antibody therapy because it is located in the intracellular domain, which trastuzumab does not target. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. HER2V777L x ∧ Mutation x ∧ Resistance y ∧ AntibodyTherapy y ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ IntracellularDomain z ∧ Located e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Trastuzumab z ∧ Target e2 ∧ Agent e2 z ∧ Patient e2 x ∧ ¬Target e2"

(* Explanation 4: The location of the HER2 V777L mutation in the intracellular tyrosine kinase domain can lead to resistance to trastuzumab, as trastuzumab targets the extracellular domain and does not affect the intracellular domain. *)
axiomatization where
  explanation_4: "∃x y z e1 e2 e3. HER2V777L x ∧ Mutation x ∧ IntracellularDomain y ∧ TyrosineKinaseDomain y ∧ Located e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Resistance z ∧ Trastuzumab z ∧ Lead e2 ∧ Agent e2 y ∧ Patient e2 z ∧ ExtracellularDomain z ∧ Target e3 ∧ Agent e3 z ∧ Patient e3 y ∧ ¬Affect e3"

theorem hypothesis:
  assumes asm: "HER2V777L x ∧ Resistance y ∧ Trastuzumab z"
  (* Hypothesis: HER2 V777L may cause resistance to trastuzumab, as trastuzumab binds to the extracellular kinase domain, whereas the mutation is in the intracellular kinase domain. *)
  shows "∃x y z e1 e2. HER2V777L x ∧ Resistance y ∧ Trastuzumab z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ To y z ∧ Bind e2 ∧ Agent e2 z ∧ Patient e2 x ∧ ExtracellularDomain x ∧ IntracellularDomain x"
proof -
  (* From the premise, we have known information about HER2V777L, Resistance, and Trastuzumab. *)
  from asm have "HER2V777L x ∧ Resistance y ∧ Trastuzumab z" by blast
  (* Explanation 2 provides that the HER2 V777L mutation is located in the intracellular tyrosine kinase domain, which is not targeted by trastuzumab, and this location can lead to resistance to antibody therapy. *)
  (* Logical relation: Implies(C, D) and Implies(C, E) *)
  (* We can infer that the HER2 V777L mutation is not targeted by trastuzumab and can lead to resistance. *)
  then have "HER2V777L x ∧ Resistance y ∧ Trastuzumab z ∧ IntracellularDomain x ∧ ¬Target e2" sledgehammer
  (* Explanation 4 states that the location of the HER2 V777L mutation in the intracellular tyrosine kinase domain can lead to resistance to trastuzumab, as trastuzumab targets the extracellular domain and does not affect the intracellular domain. *)
  (* Logical relation: Implies(C, H) and Implies(H, I) *)
  (* We can infer that the HER2 V777L mutation can lead to resistance to trastuzumab and trastuzumab targets the extracellular domain. *)
  then have "HER2V777L x ∧ Resistance y ∧ Trastuzumab z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ To y z ∧ Bind e2 ∧ Agent e2 z ∧ Patient e2 x ∧ ExtracellularDomain x ∧ IntracellularDomain x" <ATP>
  then show ?thesis <ATP>
qed

end
